Patent · US Active

Engineered deoxyribose-phosphate aldolases

US11274286B2 · kind B2 · utility

1Cited by
134References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2019
Grant dateMar 15, 2022
Priority date
Expiry dateJul 2, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y401/02004
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides engineered deoxyribose-phosphate aldolase polypeptides useful under industrial process conditions for the production of pharmaceutical and fine chemical compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.